is retatrutide fda approved yet Retatrutide's TRIUMPH-1 result explains why people care: Lilly reported 28.3% mean body-weight loss at 80 weeks on 12 mg, and 45.3% losing at least 30%. But the more interesting story the Retatrutide Availability & Timeline |

Is retatrutide available to use in the UK outside of a clinical trial

HbA1c Reductions Across Follow-Up Overall, the average follow-up duration was 5.8 months, with longer follow-up times in body weight (8.2 months) and HbA1c cohorts (8.1 months

Members get access to: Clinicians trained in obesity medicine, self-paced lifestyle change program designed by doctors, psychologists, and behavioral scientists & our exclusive in-app community

If Phase 3 confirms the Phase 2 numbers, retatrutide would represent a significant step beyond the current gold standard, not just an incremental improvement

Quality control testing is substantially more complex for retatrutide

GLP-1R: glucagon-like peptide-1 receptor